Pacira BioSciences, Inc. - Common Stock (PCRX)
Frequently Asked Questions About Pacira BioSciences, Inc. - Common Stock (PCRX)
Are there other products in development by Pacira BioSciences, Inc.?
Yes, Pacira BioSciences, Inc. continually invests in research and development to expand its product pipeline. The company explores new formulations and indications for existing products, as well as new therapies designed to address unmet medical needs in pain management.
Has Pacira BioSciences, Inc. received any FDA approvals?
Yes, Pacira BioSciences, Inc. received FDA approval for EXPAREL® in October 2011. Additionally, the company has pursued further indications and formulations, enhancing its product offerings and positioning within the broader pain management market.
How can investors learn more about Pacira BioSciences, Inc.?
Investors can learn more about Pacira BioSciences, Inc. through the company's official website, where they can find information on its financial performance, product pipeline, and corporate news. Additionally, the company regularly publishes quarterly earnings reports and participates in investor conferences, providing further insights into its operations and future prospects.
How does Pacira BioSciences, Inc. contribute to the fight against the opioid crisis?
Pacira BioSciences, Inc. contributes to the fight against the opioid crisis by providing innovative alternatives to opioids for pain management. By focusing on non-opioid treatments like EXPAREL®, the company aims to reduce the reliance on opioids in postoperative care, ultimately helping decrease the number of patients at risk of opioid addiction.
How does Pacira BioSciences, Inc. focus on patient safety?
Pacira BioSciences, Inc. is committed to patient safety by developing non-opioid alternatives for pain management that are designed to reduce the risk of side effects and opioid dependency. The company conducts extensive clinical trials and adheres to regulatory standards to ensure the safety and efficacy of its products.
Is Pacira BioSciences, Inc. a publicly traded company?
Yes, Pacira BioSciences, Inc. is a publicly traded company, listed on the NASDAQ stock exchange under the ticker symbol PCRX. Being a publicly traded entity allows the company to raise capital through the sale of its shares and provides liquidity for its investors.
What are the key benefits of using EXPAREL® for patients?
The key benefits of using EXPAREL® include effective, long-lasting pain relief from a single administration, a reduced need for opioids during recovery, and improved overall patient satisfaction. By minimizing the use of opioids, EXPAREL® helps in reducing the risk of opioid-related side effects and dependency.
What collaborations or partnerships does Pacira BioSciences, Inc. have?
Pacira BioSciences, Inc. engages in various collaborations and partnerships with healthcare organizations, research institutions, and other biopharmaceutical companies. These collaborations aim to enhance research, expand clinical applications, and improve the accessibility of its innovative pain management solutions to healthcare providers and patients.
What does Pacira BioSciences, Inc. do?
Pacira BioSciences, Inc. is a biopharmaceutical company specializing in innovative non-opioid pain management solutions. The company focuses on developing and commercializing pharmaceuticals that provide effective pain relief while minimizing the risks associated with opioid use. Their flagship product, EXPAREL®, is an injectable formulation of bupivacaine designed to control postoperative pain.
What is EXPAREL® and how is it used?
EXPAREL® is a long-acting local anesthetic that contains bupivacaine and is used for postoperative pain management. It provides effective pain relief at the surgical site for up to 72 hours after administration, reducing the need for opioid analgesics in the postoperative setting and helping to mitigate the risks of opioid dependency.
What is the company's mission?
Pacira BioSciences, Inc. aims to transform the treatment of pain management by providing innovative, clinically effective, and non-opioid solutions. Their mission is to enhance patients' quality of life and improve surgical outcomes while addressing the growing concerns around opioid medications.
What is the corporate culture at Pacira BioSciences, Inc.?
The corporate culture at Pacira BioSciences, Inc. is centered around collaboration, innovation, and a patient-first approach. The company encourages an open exchange of ideas among employees, fostering an environment where creativity and teamwork contribute to developing groundbreaking solutions in pain management.
What is the significance of Pacira BioSciences, Inc.'s educational initiatives?
Pacira BioSciences, Inc. invests in educational initiatives aimed at healthcare professionals to raise awareness about the benefits of non-opioid pain management. Through these initiatives, the company seeks to promote best practices in pain management and improve patient outcomes in surgical care.
What sets Pacira BioSciences, Inc. apart from its competitors?
Pacira BioSciences, Inc. differentiates itself from competitors through its commitment to developing non-opioid pain management solutions, extensive clinical data supporting its products, and a focus on improving patient care in surgical settings. The company's innovative technology and strong emphasis on safety also contribute to its unique position in the market.
What types of studies does Pacira BioSciences, Inc. conduct?
Pacira BioSciences, Inc. conducts a range of clinical studies, including preclinical and phase clinical trials, to evaluate the safety and efficacy of its products. These studies are an essential part of its development process and are aimed at ensuring that its products meet the high standards required for regulatory approval and best practice clinical use.
When was Pacira BioSciences, Inc. founded?
Pacira BioSciences, Inc. was founded in 2006. Since its inception, the company has been dedicated to advancing technologies aimed at improving pain management and enhancing patient outcomes in surgical settings.
Where is Pacira BioSciences, Inc. headquartered?
Pacira BioSciences, Inc. is headquartered in Parsippany, New Jersey. This location serves as the central hub for the company’s research, development, and corporate operations.
Who are the key executives at Pacira BioSciences, Inc.?
The leadership team at Pacira BioSciences, Inc. includes experienced professionals from various sectors of the biopharmaceutical industry. The executive team works collaboratively to drive the company's strategic vision and operational excellence, ensuring that Pacira remains at the forefront of innovative pain management solutions.
What is the current price of Pacira BioSciences, Inc. - Common Stock?
The current price of Pacira BioSciences, Inc. - Common Stock is 24.29
When was Pacira BioSciences, Inc. - Common Stock last traded?
The last trade of Pacira BioSciences, Inc. - Common Stock was at 4:00 pm EDT on April 3rd, 2025
What is the market capitalization of Pacira BioSciences, Inc. - Common Stock?
The market capitalization of Pacira BioSciences, Inc. - Common Stock is 1.08B
How many shares of Pacira BioSciences, Inc. - Common Stock are outstanding?
Pacira BioSciences, Inc. - Common Stock has 44.45M shares outstanding.